uniQure to Announce First Quarter 2026 Financial Results
uniQure (NASDAQ: QURE) will report first quarter 2026 financial results before market open on Tuesday, May 5, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
uniQure (NASDAQ: QURE) will report first quarter 2026 financial results before market open on Tuesday, May 5, 2026. Management will host a conference call at 8:30 a.m. ET the same day. The live webcast and a 90-day replay will be available in the Events & Presentations section of the company website.
Analysts may access the live call by dialing the provided numbers and entering conference ID 4607289. Participants are asked to join 15 minutes before start time.
Details
News Market Reaction – QURE
On Apr 28, the day this news came out, QURE closed 0.84% above the previous close.
Data tracked by StockTitan Argus for the Apr 28 session.
Key Figures
- Earnings release date
- May 5, 2026
- First quarter 2026 financial results before market open
- Conference call time
- 8:30 a.m. ET
- Management earnings call on May 5, 2026
- Webcast archive length
- 90 days
- Replay of earnings call available on investor website
- Domestic dial-in
- (800) 715-9871
- Toll-free number for analysts to join Q&A
- International dial-in
- (646) 307-1963
- Number for analysts to access live call
- Conference ID
- 4607289
- Access code for live earnings call Q&A
Previous Earnings date Reports
-
Announced timing of 2025 year-end results and accompanying conference call.
-
Set date and call details for Q3 2025 financial results release.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
~ uniQure to host earnings call on Tuesday, May 5, 2026 at 8:30 a.m. ET ~
LEXINGTON, Mass. and AMSTERDAM, April 28, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report first quarter 2026 financial results before market open on Tuesday, May 5, 2026. Management will then host a conference call at 8:30 a.m. ET.
The event will be webcast under the Events & Presentations section of uniQure’s website at https://www.uniqure.com/investors-media/events-presentations, and following the event a replay will be archived for 90 days. Analysts wishing to participate in the question and answer session should access the live call by dialing (646) 307-1963 or toll-free (800) 715-9871 and entering conference ID 4607289. If you are joining the conference call, please join 15 minutes before the start time.
About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. The approvals of uniQure’s gene therapy for hemophilia B – an historic achievement based on more than a decade of research and clinical development – represent a major milestone in the field of genomic medicine and ushers in a new treatment approach for patients living with hemophilia. uniQure is now advancing a pipeline of proprietary gene therapies for the treatment of patients with Huntington's disease, refractory temporal lobe epilepsy, Fabry disease, and other severe diseases. www.uniQure.com
uniQure Contacts:
| FOR INVESTORS: | FOR MEDIA: | |
| Chiara Russo | Tom Malone | |
| Direct: 781-491-4371 | Direct: 339-970-7558 | |
| Mobile: 617-306-9137 | Mobile:339-223-8541 | |
| c.russo@uniQure.com | t.malone@uniQure.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.